Results 131 to 140 of about 27,891 (163)

Mutations in Duchenne Muscular Dystrophy

Archives of Neurology, 1988
The nature of the mutations in Duchenne muscular dystrophy (DMD) has implications not only for genetic science but for prevention and patient care. Everyone agrees on this. The crux of the controversy is whether the mutation rate is equal among males and females.
openaire   +2 more sources

Duchenne muscular dystrophy and epilepsy

Neuromuscular Disorders, 2013
Cognitive and behavioral difficulties occur in approximately a third of patients with Duchenne muscular dystrophy. The aim of our study was to assess the prevalence of epilepsy in a cohort of 222 DMD patients. Epileptic seizures were found in 14 of the 222 DMD patients (6.3%). The age of onset ranged from 3 months to 16 years (mean 7.8).
Pane M, MESSINA, Sonia, Bruno C, D'Amico A, Villanova M, Brancalion B, Sivo S, Bianco F, Striano P, Battaglia D, Lettori D, VITA, GIANLUCA, Bertini E, Gualandi F, Ricotti V, Ferlini A, Mercuri E.   +16 more
openaire   +2 more sources

Treatment of Duchenne's Muscular Dystrophy

JAMA: The Journal of the American Medical Association, 1982
To the Editor.— The recent article by Crisp and colleagues (1982;247:478) and the accompanying editorial by Shelborne (1982;247:496), both of which emphasize the value of early diagnosis in Duchenne's muscular dystrophy (DMD), are highly commendable and may help to prevent needless tragedy and suffering.
openaire   +2 more sources

Pharmacotherapy of Duchenne Muscular Dystrophy

2019
Drug development and pharmacotherapy of rare pediatric diseases have significantly expanded over the last decade, in part due to incentives and financial support provided by governments, regulators, and nonprofit foundations. Duchenne muscular dystrophy (DMD) is among the most common rare pediatric disorders, and clinical trials of therapeutic ...
openaire   +2 more sources

CRISPR-Editing Therapy for Duchenne Muscular Dystrophy

Human Gene Therapy, 2023
Rhonda Bassel-Duby, Francesco Chemello
exaly  

Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update

Genes, 2020
Zhitao Su, Zheng Zhang, Chengmei Sun
exaly  

The Immune System in Duchenne Muscular Dystrophy Pathogenesis

Biomedicines, 2021
Yvan Torrente, Chiara Villa, Andrea Farini   +2 more
exaly  

Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)

Journal of Pediatrics, 2009
Paul Romitti, Timothy Miller, Emma Ciafaloni   +2 more
exaly  

Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center

Journal of Comparative Effectiveness Research, 2020
Brenda Wong, James Signorovitch, Cuixia Tian   +2 more
exaly  

Prevention of Pulmonary Morbidity for Patients With Duchenne Muscular Dystrophy

Chest, 1997
Yuka Ishikawa, John Bach, Heakyung Kim   +2 more
exaly